This week’s research roundup features a phase two study of pembrolizumab combined with chemoradiotherapy as initial treatment for anaplastic thyroid cancer.
This week’s research roundup features a study on antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
A Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.
This week’s research roundup features a study on glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to chemotherapy by abrogating the topBP1/ATR-mediated DNA damage response.
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews. This week’s featured abstract is on discovery, validation, and application of novel methylated DNA markers for detection of esophageal cancer in plasma.
This week’s research roundup features a study on how mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.
Traditionally, Mayo Clinic’s Simulation Center is used for surgical procedures and teaching students how to run a code. Mayo Clinic pathology consultant Karen Fritchie, M.D., recently developed a new and innovative way to use the center.
This week’s research roundup features research on the Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol.